ISSUE 19 · MAY 28, 2026 · BBWI $17.76
Catalyst Calendar — every dated catalyst across every ticker we cover: calendar.turnaroundradar.com
On a Tuesday morning in January 2026, a woman in Presque Isle, Maine walked into her local Bath & Body Works to buy the candle she had been buying every winter for six years — Mahogany Teakwood, three-wick, the one that made the house smell like a ski lodge. The store was closed. Not temporarily. Permanently. It was one of 92 Bath & Body Works locations shuttered since February 2025 — 62 in the U.S., 30 internationally — as the company pulled back from malls that no longer justified the rent.
That same week, the Bath & Body Works iOS app sat at 4.0 stars across more than one million ratings. Users praised the easy checkout, the rewards integration, the seasonal fragrance discovery. The app was shipping three-wicks to the woman's zip code in two days.
Two numbers. Same brand. Same week. One says the customer is leaving. The other says the customer never left — she just moved online.
The trade is built on which version of Bath & Body Works is real.
How Bath & Body Works got to $17.76
In July 2025 the stock touched $33.96. On May 22, 2026, it closed at $17.76. The 52-week low was $14.28, hit in early 2026. The stock has fallen 47.7% from the 52-week high and sits 24% above the 52-week floor.
The decline has three named causes and one structural one.
Named cause 1: a Q3 FY2025 earnings miss that broke the stock. In late 2025, Bath & Body Works reported third-quarter earnings that missed both revenue and EPS estimates. The stock plunged nearly 25% in a single session. Management unveiled the "Consumer First Formula" — a multi-year turnaround plan — but the market heard "multi-year" and sold first, asked questions later.
Named cause 2: two C-suite departures in twelve months. In May 2025, CEO Gina Boswell was replaced by Daniel Heaf, a former Nike and Burberry executive brought in to reposition the brand. Boswell had come from Unilever in December 2022 and spent two and a half years stabilizing the company post-L Brands spinoff. Heaf arrived with a mandate to rebuild — but before the rebuilding could show results, CFO Eva Boratto announced in May 2026 that she would leave by June 12. Tom Javitch, a 16-year company veteran, stepped into the interim role. The market does not reward a turnaround CEO who loses his CFO before the first full earnings cycle.
Named cause 3: tariff guidance that scared more than it should have. For fiscal 2026, management guided net sales down 4.5% to 2.5%, with adjusted EPS of $2.40 to $2.65 — a meaningful step-down from the prior year's $3.21. Gross margin was expected to compress approximately 270 basis points, driven by tariffs, crude oil inflation, and category mix. The guide was conservative by design: 85% of Bath & Body Works' manufacturing is domestic, which insulates the supply chain far more than most specialty retailers, but the headline numbers spooked a market already skeptical of the turnaround timeline.
Structural cause: the promotion model broke, and nobody agreed on what replaces it. Bath & Body Works built a $7.3 billion business on the "Buy 3, Get 3 Free" model. Semi-Annual Sales. Perpetual 50%-off events. The brand trained a generation of consumers to never pay full price. When the company began pulling back from deep discounting in 2024 and 2025 — eliminating the signature B3G3 in favor of fewer, more targeted promotions — Reddit called it a "total identity crisis." Customer traffic declined. Comp sales went negative. The pricing pivot is the root cause of the stock decline, because it calls into question the one thing investors thought they understood: who the Bath & Body Works customer is.
That is how Bath & Body Works got to $17.76.
undefined
What the financials show
The company is not bleeding. Revenue is declining, but slowly. Cash flow is strong. Debt is manageable.
Metric | FY2025 (ended Feb 2026) | FY2026 Guide | Reality check |
|---|---|---|---|
Revenue | $7.291B (flat YoY) | -4.5% to -2.5% | First sustained decline post-spinoff |
Q1 2026 revenue | $1.4B (-3.2%) | Beat guidance | Better-than-feared, stock jumped 17% |
Gross margin (FY25) | 44.3% | -270bp in Q1 | Tariffs + crude oil + mix shift |
Adj. EPS (FY25) | $3.21 | $2.40-$2.65 | ~20% decline YoY |
Free cash flow | $660M | — | Covers dividend + debt service |
Net debt | ~$3.3B | — | $636M cash vs $3.9B LT debt |
Store count | 1,927 US/CA + 573 intl | -92 since Feb 2025 | Mall pullback accelerating |
P/E (fwd FY26) | — | 6.7x-7.4x | Deep value territory for specialty retail |
FCF yield | — | ~16.6% | Exceptionally high |
EV/EBITDA | — | ~5.8x | Below historical avg of ~10x |
The story this table tells is "a mature specialty retailer absorbing a voluntary pricing reset, a CEO transition, and tariff headwinds while still throwing off $660 million in free cash flow." Not "a brand in collapse."
At 6.7x-7.4x forward earnings and a 16.6% free cash flow yield, the stock is priced as though the Consumer First Formula will fail. If it works — even partially — the multiple expansion alone could return 30-50% from here.
Methodology and sample sizes
Every claim about consumer belief in this report is sourced and counted. Here is what was surveyed for the Bath & Body Works analysis as of May 28, 2026.
Channel | Sample | Window | What it measures |
|---|---|---|---|
Customer reviews (aggregate) | ~1,017,717 | Last 12-36 months | Consumer trust, complaint pattern, star distribution |
ConsumerAffairs | 766 reviews | Lifetime + recent 6mo | Star distribution, 1-star tail, complaint themes |
Trustpilot US | 1,576 reviews | Lifetime + recent 6mo | Star distribution, 1-star concentration |
SiteJabber | 672 reviews | Lifetime | Cross-platform validation |
Yelp (brand page) | 14,703 reviews | Lifetime | Store-level experience (balanced platform) |
Apple App Store (BBW iOS) | 1,000,000+ ratings | Lifetime | Digital-shopping experience |
Employee reviews (aggregate) | ~21,987 | Last 24 months | Employee morale, CEO approval, outlook |
Glassdoor | 11,135 reviews | Trend | Rating 3.8, 72% recommend, 55% positive outlook |
Indeed | 10,852 reviews | Trend | Cross-platform validation |
Financial / management voice | Q4 FY25 + Q1 FY26 calls + 8-K filings | FY25-26 | Guidance language, turnaround milestones |
CEO transition trail | 2 CEO changes + 1 CFO departure in 13 months | 2025-26 | Heaf (Nike) → Consumer First Formula |
Note on channels: Bath & Body Works' consumer voice is extensive. Unlike thinner-coverage tickers where complaint platforms are sparse, BBWI has deep data across every channel — over 1 million app ratings, nearly 15,000 Yelp reviews, and active Reddit/TikTok communities. The statistical tests below are well-powered.
Statistical test: how concentrated is the complaint, and is it the brand or the platform?
Question 1 — Is the ConsumerAffairs 1-star concentration statistically extreme?
ConsumerAffairs records 766 Bath & Body Works reviews. The distribution: 1-star 511 (66.7%), 2-star 108 (14.1%), 3-star 25 (3.3%), 4-star 14 (1.8%), 5-star 108 (14.1%). The weighted average is 1.83 stars.
At n=766, the 95% confidence interval around the 66.7% one-star share is 63.4% to 70.0%. Even the lower bound exceeds two-thirds of all reviews. The 1-star bin is 4.7x the size of the 5-star bin. This is not noise — the reviewer pool is systematically self-selecting on grievance, and the grievance is consistent.
The formal test: A one-proportion Z-test against a baseline of 40% (the typical retail complaint-platform 1-star share across specialty retail peers) yields Z = 15.09, p < 0.0001. The null hypothesis — that BBWI's one-star share is no different from typical specialty retail — is rejected at every conventional significance level. Bath & Body Works' complaint surface is measurably more negative than its category peers.
undefined
Question 2 — Is this a Bath & Body Works problem, or a platform problem?
Platform | Rating | Sample | Type |
|---|---|---|---|
Apple App Store | 4.0 | 1,000,000+ | Product discovery |
Yelp (brand) | 3.6 | 14,703 | Store experience (balanced) |
Glassdoor (employee) | 3.8 | 11,135 | Employee satisfaction |
SiteJabber | 2.6 | 672 | Complaint-leaning |
ConsumerAffairs | 1.83 | 766 | Complaint-heavy |
Trustpilot | 1.6 | 1,576 | Complaint-heavy |
The product-experience platforms (App Store + Yelp) carry a weighted average of 3.99 stars across 1,014,703 data points. The complaint platforms (Trustpilot + ConsumerAffairs + SiteJabber) carry a weighted average of 1.88 stars across 3,014 reviews.
The divergence is 2.11 stars. The customer who shops loves it. The customer who complains hates it. And the two groups are not talking to each other.
undefined
This is not a broken brand. This is a brand with a broken service layer. The product discovery engine — the seasonal candle drops, the app experience, the in-store sensory marketing — is working at 4.0 stars. The post-purchase experience — refunds, exchanges, reformulated products, eliminated promotions — is working at 1.6.
What the financials do not show
The financials do not show that Bath & Body Works still has one of the most engaged consumer communities in specialty retail. The Reddit community actively tracks every seasonal release. TikTok "Bath & Body Works haul" videos routinely clear six figures of views. The iOS app has over one million ratings at 4.0 — not a legacy score from years past, but a live reflection of customers who are actively shopping, browsing, and buying through the digital channel.
CEO Daniel Heaf told Yahoo Finance that the company has been "doing a lot of near-shoring and on-shoring" for years, with 85% of manufacturing domestic. This is not a company scrambling to reroute supply chains — it is a company that already has the supply chain advantage most retailers wish they had.
The "Everyday Luxuries" collection launched in summer 2026 represents the first product line explicitly designed under Heaf's direction — premium positioning, elevated packaging, higher price points but with a quality story attached. If the collection lands with the same consumer who gives the app 4.0 stars, the pricing pivot has a pathway.
The Semi-Annual Sale — historically the company's largest traffic driver, typically held in June-July — will be the first major promotional event under the new pricing philosophy. How deeply the company discounts, and how loudly the consumer responds, is the real-time readout on whether the coupon cliff has a bottom.
What is actually happening, and what is not
What IS recovering:
Q1 2026 beat guidance on both revenue and EPS. The stock jumped 17% on the print.
85% domestic manufacturing insulates the company from tariff volatility better than virtually any specialty retail peer.
Daniel Heaf brings a track record of digital transformation from Nike and Burberry — exactly the skill set a promotion-dependent brand needs to build a direct-to-consumer flywheel.
Free cash flow of $660 million covers the dividend, debt service, and leaves room for reinvestment.
International franchise partners continue to deliver growth across 45+ countries.
What is NOT recovering:
U.S. comparable sales remain negative. The domestic consumer has not yet re-engaged at full price.
The CFO departure adds execution risk to a turnaround that is already in its early innings.
Gross margins are compressing — Q1 2026 adjusted gross margin was 42.7%, down 270 basis points.
The debt load ($3.9B long-term) limits the company's ability to invest aggressively in the brand reset.
Consumer complaints about reformulation — thinner soaps, weaker candle throws, cheaper-feeling packaging — are growing, not shrinking.
What is unknown:
Whether the "Consumer First Formula" can drive comp store sales positive by 2H 2026 as management hopes.
Whether Heaf's Nike playbook (premium positioning, digital-first, scarcity marketing) translates to a mass-market fragrance brand built on volume.
Whether a permanent CFO hire will stabilize the leadership team before the Q2 print.
Whether the Semi-Annual Sale in June/July 2026 will be aggressive enough to bring back the coupon-driven core customer, or whether holding the line on price will push her permanently to private-label alternatives.
Important caveats
Platform selection bias. Trustpilot and ConsumerAffairs disproportionately attract dissatisfied customers. The 1.6 and 1.83 averages on those platforms are NOT representative of the full customer base — the 4.0 App Store score with 1M+ ratings is a far larger sample drawn from active shoppers.
The Z-test baseline is estimated. The 40% one-star baseline for specialty retail is derived from cross-category averages on complaint platforms, not a published benchmark. The Z-statistic (15.09) is so extreme that the conclusion holds under any reasonable baseline assumption.
Reformulation claims are qualitative. Multiple reviewers cite thinner soaps, weaker candle fragrances, and changed formulas. These claims are not independently verified through laboratory analysis. Management has not publicly acknowledged product reformulation.
Turnaround timelines are management's. The "2H 2026 into 2027" timeline for Consumer First Formula impact is the company's own guidance. No independent verification of progress against internal milestones is possible from public data.
The debt load is real. At $3.9 billion in long-term debt against $636 million in cash, the balance sheet limits strategic flexibility. A prolonged sales decline could force more aggressive cost-cutting that further damages the consumer experience.
undefined
The setup
The market is pricing Bath & Body Works as a mature retailer in permanent decline. At 6.7x forward earnings and a 16.6% FCF yield, the stock trades at less than half its historical multiple. The question is whether the new CEO can convert a promotion-dependent franchise into a premium direct-to-consumer brand — and whether the consumer will follow.
Scenario | Probability | 12-month target | Rationale |
|---|---|---|---|
Bear: Reset fails | 25% | $12-$14 | Comps stay negative, reformulation backlash deepens, CFO search drags, multiple contracts further |
Base: Slow grind | 45% | $20-$24 | Q2/Q3 stabilization, new CFO hired, SAS sale decent but not great, multiple grinds toward 8x |
Bull: Heaf delivers | 25% | $28-$32 | Comps inflect positive by Q3, Everyday Luxuries lands, new CFO in place, re-rate to 10x+ |
Outlier bull | 5% | $35+ | Activist or PE interest at sub-$4B EV, take-private bid, or blockbuster holiday 2026 |
Expected value (probability-weighted): ~$21.50. Against a current price of $17.76, the setup offers roughly 21% expected upside — but only if you can tolerate the path. The bear scenario has real teeth: a company with $3.9 billion in debt, a departing CFO, and negative comps does not have unlimited time to prove the turnaround works.
The trade
Now ($17.76): The stock is cheap on every traditional metric — P/E, EV/EBITDA, FCF yield. The Q1 beat showed the business is not falling off a cliff. But cheap is not enough. You need a catalyst.
Next catalyst — Semi-Annual Sale (June-July 2026): The SAS is the single largest promotional event of the year. Under the old model, it was 75%-off everything, doorbuster madness, lines around the block. Under the new model, it will be more restrained. How restrained, and how the customer reacts, is the first live datapoint on whether the pricing pivot works.
Decider date — Q2 2026 earnings (~late August 2026): This is the print that captures the SAS performance, the first full quarter under interim CFO Tom Javitch, and the first quarter where Consumer First Formula initiatives should be visible in the numbers. A comp-sales inflection here, even to flat, would be the first hard evidence that Heaf's strategy is working. A miss, with comps still deeply negative, resets the bear thesis.
The August read
When Bath & Body Works reports Q2 2026 in late August, we will know:
Whether the Semi-Annual Sale drove traffic or whether the consumer refused to engage without the old discount levels.
Whether the interim CFO transition disrupted the financial reporting rhythm or whether the 16-year insider kept the machine running.
Whether the first Consumer First Formula initiatives — Everyday Luxuries, new fragrance architecture, elevated packaging — moved the needle on average transaction value.
If comps inflect to flat or better and gross margins stabilize, the stock re-rates quickly from 7x to 9x+ forward earnings — a $24-$28 range from here. If comps deteriorate further and the SAS disappoints, the $14 52-week low is back in play.
Subscribers will get the follow-up analysis the day of the Q2 print. Add calendar.turnaroundradar.com now — the BBWI Q2 earnings and Semi-Annual Sale are already on the calendar.
Turnaround Radar — data-driven turnaround analysis for stocks the market has left for dead.